For the latest updates on how we are managing changes due to COVID-19 please click here.

Ophthalmology Innovation Summit At ASCRS 2014

Ora, Inc., the world’s leading independent, full- service ophthalmic contract research organization (CRO) and product development firm, announced today that they are the exclusive sponsor for the upcoming Ophthalmology Innovation Summit (OIS) during ASCRS 2014 in Boston, MA.

Presenting at the meeting will be two co-moderators, a prestigious group of panelists including several physicians, a representative from the FDA, and Ora executive, Aron Shapiro.

Aron Shapiro leads Ora’s business unit that supports clients as they develop products for a number of therapeutic areas including retina, glaucoma, infection, inflammation, and refractive disorders, as well as diagnostic and surgical devices. He consults for venture capital investors and strategic acquirers throughout the life cycle of ophthalmic assets. Mr. Shapiro is widely published and writes a monthly column in Retina Today.

April 24, 2014, 1:30PM – 2:15PM

Seaport Hotel, 200 Seaport Blvd, Boston, MA

Co-moderators: Dick Lindstrom, MD, Founder & Attending Surgeon Minnesota Eye Consultants and Gil Kilman, MD, Managing Director InterWest Partners
Panelists include:

  • Malvina Eydelman, Director, Division of Ophthalmic Device Evaluation FDA
  • Aron Shapiro, Vice President Ora, Inc.
  • Donald Tan, MD, Medical Director Singapore National Eye Centre
  • Michael Mrochen, PhD, Founder & CEO IROC Science to Innovation
  • Roberto Zaldivar, MD, President Instituto Zaldivar S.A.
  • Matteo Pivovella, MD, Director Centro di Microchirurgia Ambulatoriale


The Role of OUS Clinical Studies & Commercialization in Ophthalmic Innovation

Media Contact:

Jessica Griffith
Pascale Communications, LLC